Compare BKSY & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKSY | ARCT |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.7M | 526.5M |
| IPO Year | N/A | N/A |
| Metric | BKSY | ARCT |
|---|---|---|
| Price | $16.97 | $6.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $29.00 | ★ $38.67 |
| AVG Volume (30 Days) | ★ 2.0M | 942.4K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,731,000.00 | $97,601,000.00 |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $33.87 | $26.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.15 | $5.85 |
| 52 Week High | $33.20 | $24.17 |
| Indicator | BKSY | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 28.73 |
| Support Level | $16.10 | $5.85 |
| Resistance Level | $18.39 | $6.90 |
| Average True Range (ATR) | 1.33 | 0.44 |
| MACD | 0.52 | 0.34 |
| Stochastic Oscillator | 76.25 | 14.65 |
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.